TOTAL ALLERGY CARE for HEALTH PROFESSIONALS
Visit RhinocortProfessional.com for information about RHINOCORT® Allergy Spray resources.
to order samples and resources with ZYRTEC ZIPLINE®.

Children’s ZYRTEC® Clinical Data

Consistent improvement of symptoms throughout the 2-week treatment period

Reduction from baseline in total symptom severity complex (TSSC)*†1

  • 37% and 40% reduction observed after 2 weeks of treatment in the 10-mg group
  • 63% and 40% reduction observed after 2 weeks of treatment in the 5-mg group

All studies are multicenter, randomized, placebo-controlled, double-blind in children ages 2 to 11 years with previous diagnosis of SAR, and adequate minimum duration (2 weeks).

*TSSC = Total Symptom Severity Complex.

†Adjusted mean change relative to baseline.

Reference: 1. Urdaneta ER, Przygoda PA, Lin CL, et al. Regular use of cetirizine demonstrates consistent relief from symptoms of seasonal allergic rhinitis in children. J Allergy Clin Immunol. 2011;127(suppl 2):AB 202.

Learn more about Children's ZYRTEC®

Go

TBD TBD

View Children's ZYRTEC® tolerability profile

Go

Caregiver Brochure

Help educate children and caregivers about allergies with an educational brochure and storybook.

Download Now Order Resources
Help children and caregivers understand allergies Help children and caregivers understand allergies

RHINOCORT® is a licensed trademark of AstraZeneca AB.

©Johnson & Johnson Consumer Inc. 2019. All rights reserved. The third-party trademarks used herein are registered trademarks of their respective owners and not Johnson & Johnson Consumer Inc. This site is published by Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division, which is solely responsible for its contents. This website is intended for U.S. healthcare professionals only. Questions or comments? Call our Customer Care Center for Healthcare Professionals at 1-866-948-6883.